Literature DB >> 8822201

Activation of retinoid receptors RAR alpha and RXR alpha induces differentiation and apoptosis, respectively, in HL-60 cells.

K Mehta1, T McQueen, N Neamati, S Collins, M Andreeff.   

Abstract

Induction of granulocytic differentiation in HL-60 myeloid leukemia cells by retinoids is followed by their death via apoptosis. Retinoids are known to mediate their biological effects through at least two distinct types of nuclear receptors, the retinoic acid receptors and retinoid X receptors. We undertook to characterize the potential role of these receptors in inducing differentiation and apoptosis by retinoids. For this, we used a previously described variant of an HL-60 cell line (HL-60R) in which retinoid receptor function has been abrogated due to a trans-dominant negative mutation. Retroviral vector-mediated gene transfer was used to introduce the normal retinoic acid receptor (RAR alpha) or retinoid X receptor (RXR alpha) into HL-60R cells. Our results suggest that ligand-induced activation of RAR alpha is sufficient to induce differentiation in HL-60 cells, whereas activation of RXR alpha can induce direct apoptosis of these cells without their prior commitment to differentiate.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8822201

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  10 in total

1.  Synergistic growth inhibition in HL-60 cells by the combination of acyclic retinoid and vitamin K2.

Authors:  Junichi Kitagawa; Takeshi Hara; Hisashi Tsurumi; Soranobu Ninomiya; Kengo Ogawa; Seiji Adachi; Nobuhiro Kanemura; Senji Kasahara; Masahito Shimizu; Hisataka Moriwaki
Journal:  J Cancer Res Clin Oncol       Date:  2010-07-31       Impact factor: 4.553

Review 2.  The multi-faceted role of retinoid X receptor in bone remodeling.

Authors:  María P Menéndez-Gutiérrez; Mercedes Ricote
Journal:  Cell Mol Life Sci       Date:  2017-01-19       Impact factor: 9.261

Review 3.  New oral chemotherapeutic agents for lung cancer.

Authors:  E M Bengtson; J R Rigas
Journal:  Drugs       Date:  1999       Impact factor: 9.546

4.  In vitro neural differentiation of CD34 (+) stem cell populations in hair follicles by three different neural induction protocols.

Authors:  Nowruz Najafzadeh; Mohsen Sagha; Shirin Heydari Tajaddod; Mohammad Ghasem Golmohammadi; Nasim Massahi Oskoui; Maryam Deldadeh Moghaddam
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-10-08       Impact factor: 2.416

5.  Identification, synthesis, and biological evaluation of the metabolites of 3-amino-6-(3'-aminopropyl)-5H-indeno[1,2-c]isoquinoline-5,11-(6H)dione (AM6-36), a promising rexinoid lead compound for the development of cancer chemotherapeutic and chemopreventive agents.

Authors:  Lian Chen; Martin Conda-Sheridan; P V Narasimha Reddy; Andrew Morrell; Eun-Jung Park; Tamara P Kondratyuk; John M Pezzuto; Richard B van Breemen; Mark Cushman
Journal:  J Med Chem       Date:  2012-06-19       Impact factor: 7.446

6.  Synergistic decrease of clonal proliferation, induction of differentiation, and apoptosis of acute promyelocytic leukemia cells after combined treatment with novel 20-epi vitamin D3 analogs and 9-cis retinoic acid.

Authors:  E Elstner; M Linker-Israeli; J Le; T Umiel; P Michl; J W Said; L Binderup; J C Reed; H P Koeffler
Journal:  J Clin Invest       Date:  1997-01-15       Impact factor: 14.808

7.  Comparative study of autophagy inhibition by 3MA and CQ on Cytarabine‑induced death of leukaemia cells.

Authors:  Caroline Palmeira dos Santos; Gustavo J S Pereira; Christiano M V Barbosa; Aron Jurkiewicz; Soraya S Smaili; Claudia Bincoletto
Journal:  J Cancer Res Clin Oncol       Date:  2014-06       Impact factor: 4.553

8.  Involvement of PKC in TPA-potentiated apoptosis induction during hemin-mediated erythroid differentiation in K562 cells.

Authors:  Chih Chung Chou; Chen Ya Hsu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-08-29       Impact factor: 3.000

9.  Identification and characterization of a phenyl-thiazolyl-benzoic acid derivative as a novel RAR/RXR agonist.

Authors:  Chie Koshiishi; Takanori Kanazawa; Eric Vangrevelinghe; Toshiyuki Honda; Shinji Hatakeyama
Journal:  Heliyon       Date:  2019-11-19

10.  The Role of Transglutaminase 2 in the Radioresistance of Melanoma Cells.

Authors:  Julia Aepler; Johanna Wodtke; Robert Wodtke; Cathleen Haase-Kohn; Reik Löser; Jens Pietzsch; Sandra Hauser
Journal:  Cells       Date:  2022-04-14       Impact factor: 7.666

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.